Company Overview and News

5
Uncertainty looms over Singapore Airlines with mixed operating stats, US-China trade spat: OCBC

2018-06-22 theedgemarkets
SINGAPORE (June 22): OCBC Investment Research is maintaining “hold” on Singapore Airlines (SIA) with unchanged forecasts and a fair value of S$11.30, in light of fluid macro conditions and the group’s recent mixed bag of operating statistics.
C6L SINGY SINGF

59
Singapore Air CEO Sees Cargo Market Cooling as Supply Adjusts

2018-06-22 theedgemarkets
(June 22): As the brewing trade battle between the U.S. and China threatens to slow demand for air freight, the market also is likely to cool as demand gets in line with supply, according to the chief executive officer of Singapore Airlines Ltd.
C6L BOE SINGY BA SINGF

5
Singapore Air CEO Sees Cargo Market Cooling - Bloomberg

2018-06-22 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C6L CPCAY 0293 SINGY CPCAF SINGF

59
Singapore Airlines to shift planes from SilkAir to budget arm Scoot

2018-06-21 theedgemarkets
SINGAPORE (June 21): Singapore Airlines Ltd said on Thursday it expected to transfer some jets from its SilkAir regional airline to budget carrier Scoot, allowing it to compete more effectively against low-cost rivals like AirAsia Group Bhd and Lion Group.
C6L BOE SINGY BA SINGF

59
Singapore Airlines to shift planes from SilkAir to budget arm Scoot

2018-06-21 channelnewsasia
SINGAPORE: Singapore Airlines Ltd said on Thursday (Jun 21) it expected to transfer some jets from its SilkAir regional airline to budget carrier Scoot, allowing it to compete more effectively against low-cost rivals like AirAsia Group Bhd and Lion Group.
C6L BOE SINGY BA SINGF

59
Singapore Airlines to shift planes from SilkAir to budget arm Scoot

2018-06-21 reuters
SINGAPORE (Reuters) - Singapore Airlines Ltd (SIAL.SI) said on Thursday it expected to transfer some jets from its SilkAir regional airline to budget carrier Scoot, allowing it to compete more effectively against low-cost rivals like AirAsia Group Bhd (AIRA.KL) and Lion Group.
C6L BOE SINGY BA SINGF

5
Commentary: Singapore Airlines to launch world's longest commercial flight - again

2018-06-20 channelnewsasia
SIA recently announced plans to re-introduce a flight they scrapped just five years ago. One aviation industry observer discusses what's changed.
C6L SINGY SINGF

59
A First Look At The Boeing 787-10's Potential

2018-06-19 seekingalpha
There are many more orders to win in the marketplace though part of demand can also be filled by the Boeing 787-9 as a competitor to the Airbus A330-300.
C6L BOE SINGY BA SINGF

5
World's five longest flights revealed - and it's not good news for Kiwi travellers

2018-06-19 nzherald.co.nz
A breakdown of the longest plane journeys in the world reveals some of the more gruelling flights airline passengers are likely to take - with many covering close to 15,000km in a single trip.
C6L SINGY SINGF

5
Be wary of pre-ticked boxes when making an online purchase, CASE warns - Channel NewsAsia

2018-06-19 channelnewsasia
SINGAPORE: Customers should be wary of pre-ticked boxes when making purchases online, the Consumers Association of Singapore (CASE) said on Tuesday (Jun 19).
C6L SINGY SINGF

5
Appointments

2018-06-16 aviationweek
Hector Zarate has been named interim president of FlightSafety Services Corp., replacing Ron Ladnier, who retires at the end of June. Most recently, Zarate, who joined FlightSafety in 1986, served as program manager for the KC-46. His Excellency Akbar Al Baker, CEO of Qatar Airways, has assumed duties as chairman of the International Air Transport Association, succeeding Goh Choon Phong, CEO of Singapore Airlines.
C6L SINGY SINGF

5
Singapore Airlines flight to Melbourne delayed after slide 'unexpectedly deployed'

2018-06-15 channelnewsasia
SINGAPORE: A Singapore Airlines (SIA) flight from Singapore to Melbourne was delayed after an evacuation slide was "unexpectedly deployed" on Friday (Jun 15).
C6L SINGY SINGF

5
Etihad Airways in talks to cancel, defer Boeing 777X orders, say sources

2018-06-14 malaymail
DUBAI, June 14 — Etihad Airways is exploring options with Boeing to cancel or defer orders for 777X jets worth billions of dollars in a fresh sign of the carrier's financial strains and potentially squeezing Boeing's newest model, four sources familiar with the matter said.
C6L AIBEF SINGY SINGF

5
Singapore Airlines investigating allegations made by passenger on delayed flight

2018-06-14 channelnewsasia
SINGAPORE: Singapore Airlines (SIA) on Thursday (Jun 14) said it was looking into claims that its cabin crew were rude to passengers on board a delayed flight to India.
C6L SINGY SINGF

5
Exclusive: Etihad Airways in talks to cancel, defer Boeing 777X orders - sources

2018-06-13 reuters
DUBAI/ABU DHABI (Reuters) - Etihad Airways is exploring options with Boeing to cancel or defer orders for 777X jets worth billions of dollars in a fresh sign of the carrier’s financial strains and potentially squeezing Boeing’s newest model, four sources familiar with the matter said.
C6L AIBEF SINGY SINGF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 82930C106